My bookmarksSign up free

Commission Implementing Decision (EU) 2026/378 of 20 February 2026 not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Decision (EU) 2026/378 of 20 February 2026 not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Decision (EU) 2026/378 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The approval of etofenprox as an active substance for use in biocidal products of product-types 8 and 18 is not renewed.

Article 2

Treated articles treated with or intentionally incorporating etofenprox for use in biocidal products of product-types 8 and 18 shall no longer be placed on the market as from 11 September 2026.

Article 3

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next